Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress on dendritic cell vaccines in cancer immunotherapy
Jifeng Yu, Haowei Sun, Weijie Cao, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

mRNA vaccines for cancer immunotherapy
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 95
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 84
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
Peng Zhang, Xinyuan Liu, Zhuoyu Gu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Glioblastoma Microenvironment and Cellular Interactions
Carmen Crivii, Adina Bianca Boşca, Carmen Stanca Melincovici, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1092-1092
Open Access | Times Cited: 45
Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments
Jenni Viivi Linnea Niemi, Aleksandr V. Sokolov, Helgi B. Schiöth
Cancers (2022) Vol. 14, Iss. 20, pp. 5163-5163
Open Access | Times Cited: 38
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
New immunotherapeutic approaches for cancer treatment
Amin Kamrani, Ramin Hosseinzadeh, Navid Shomali, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154632-154632
Closed Access | Times Cited: 27
Recent advances and future perspectives in the therapeutics of prostate cancer
Ganji Lakshmi Varaprasad, Vivek Gupta, K. Satya Prasad, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy
Anna Wróblewska, Agnieszka Szczygieł, Bożena Szermer-Olearnik, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 4521-4539
Open Access | Times Cited: 24
Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
Da Qian, Jialu Li, Mingyao Huang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114685-114685
Open Access | Times Cited: 23
Current Technologies and Future Perspectives in Immunotherapy towards a Clinical Oncology Approach
Subhamay Adhikary, Surajit Pathak, Vignesh Palani, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 217-217
Open Access | Times Cited: 10
The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 521-552
Open Access | Times Cited: 10
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines
Tengfei Liu, Wenyan Yao, Wenyu Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 29, pp. 18801-18833
Closed Access | Times Cited: 10
Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia
Cecilia Restelli, Marco Ruella, Luca Paruzzo, et al.
Blood Cancer Discovery (2024) Vol. 5, Iss. 4, pp. 234-248
Closed Access | Times Cited: 9
Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering
Jie Wang, Zongying Zhang, Rongxiang Liang, et al.
Materials Today Bio (2024) Vol. 26, pp. 101068-101068
Open Access | Times Cited: 8
Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
Yuze Wu, Ming Yi, Mengke Niu, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 739-760
Open Access | Times Cited: 8
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Ana Isabel Sebastião, Gabriel Chahade Sibanto Simões, Filomena Oliveira, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102884-102884
Open Access | Times Cited: 1
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
A Personalized Cancer Nanovaccine that Enhances T‐Cell Responses and Efficacy Through Dual Interactions with Dendritic Cells and T Cells
Seokhyeong Go, Mungyo Jung, Suyoung Lee, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 19
Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez‐Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
Yunyi Wu, Yanchun Li, Yan Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116132-116132
Open Access | Times Cited: 8
Enhanced cellular therapy: revolutionizing adoptive cellular therapy
Mengyao Xu, Na Zeng, Chen‐Qian Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
Shabnam Babaei, Manouchehr Fadaee, Hajar Abbasi‐Kenarsari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top